Search
forResearch 10 of 167
- Activity of Sorafenib against Desmoid Tumor/Deep Fibromatosis
- Molecular targeted therapies for cancer: Sorafenib mono�therapy and its combination with other therapies (Review)
- Hand-Foot and Stump Syndrome to Sorafenib
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Sorafenib-induced eruption resembling pityriasis rubra pilaris
- Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
- Sorafenib-Associated Facial Acneiform Eruption
- Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Deferasirox, an oral iron chelator, prevents hepatocarcinogenesis and adverse effects of sorafenib
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →